Focus on MedTech projects
MADIA
MADIA researched and developed a highly sensitive device for the early diagnosis of neurodegenerative disease, capable of measuring targeted biomarkers existing at low concentrations in treated cerebrospinal fluid (CSF) or blood samples. The device has been initially thought for the diagnosis of Alzheimer.
DRIVE
DRIVE researched and developed the β-system, a novel treatment for T1D and insulin-dependent T2D. The technology consists of a bio-interactive hydrogel (β-Gel) to deliver islets in a protected fashion to a surgical site, within a porous retentive microcapsule (β-Shell). A minimally invasive laparoscopic procedure will deliver the β-Shell using a specialised injection catheter β-Cath.